Prot ACP-ST-007: A Phase 2 Proof-of-Concept Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Advanced Non-small Cell Lung Carcinoma

Project: Research project

Project Details

StatusFinished
Effective start/end date7/20/15 → 7/20/18

Funding

  • PRA Health Sciences (Prot ACP-ST-007 // Prot ACP-ST-007)
  • Acerta Pharma B.V. (Prot ACP-ST-007 // Prot ACP-ST-007)